Brian J. Mehigan

Brian J. Mehigan

Auto-generated profile, based on publicly available information

Brian J. Mehigan

Department of Colorectal Surgery, St James’s Hospital, Dublin 8, Ireland

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2000 in The Lancet
Verified
Journal Article
Closed access
BMBrian J Mehigan
Brian J Mehigan
JMJohn Rt Monson
John Rt Monson
JHJohn E Hartley
John E Hartley

1 August 2015 in International Journal of Surgery
Verified
Journal Article
Closed access
HCHasanin Al Chalabi
Hasanin Al Chalabi
JLJohn Larkin
John Larkin
BMBrian Mehigan
Brian Mehigan
PMPaul McCormick
Paul McCormick
Development of an incisional hernia after abdominal surgery is a common complication following laparotomy. Following recent advancements in laparoscopic and open repair a literature review has demonstrated no difference in the short term outcomes between open and laparoscopic repair, concluding there was no favourable method of repair over the other and that both techniques are appropriate methods of surgical repair. However, long term outcomes in the available literature between these two approaches were not clearly analysed or described. The objective of this study is to assess the effectiveness and safety of laparoscopic versus open abdominal incisional hernia repair, and to evaluate the short and long term outcomes in regards to hernia recurrence using meta-analysis of all randomised controlled trials from 2008 to end of 2013. Patients who developed an abdominal hernia or abdominal incisional hernia following a laparotomy. Two methods of surgical repair, laparoscopic and open abdominal wall hernia repair. Comparison: To compare between laparoscopic and open repair in abdominal wall incisional hernia. length of hospital stay, operation time, wound infection and hernia recurrence rate. This study is a systematic review on all randomized controlled trials of laparoscopic versus open abdominal wall and incisional hernia repair. Medline, Pubmed, Cochrane library, Cinahl and Embase were the databases interrogated. Inclusion & exclusion criteria had been defined. The relevant studies identified from January 2008 to December 2013, are included in the analysis. The primary end point can be described as hernia recurrence, and secondary outcomes can be described as length of hospital stay post operatively, operation time and wound infection. Five randomized controlled trials (RCTs) were identified and included in the final analysis with a total number of 611 patients randomized. Three hundreds and six patients were in the laparoscopic group and 305 patients in the open repair group. The range of follow up in the studies was two months to 35 months. The recurrence rate was similar (P = 0.30), wound infection was higher in the open repair group (P < 0.001), length of hospital stay was not statistically different (P = 0.92), and finally the operation time was longer in the laparoscopic group but did not reach statistical significance (P = 0.05) CONCLUSION: The short and long-term outcomes of laparoscopic and open abdominal wall hernia repairs are equivalent; both techniques are safe and credible and the outcomes are very comparable.

1 March 2001 in Diseases of the Colon & Rectum
Verified
Journal Article
Closed access
JHJohn E. Hartley
John E. Hartley
BMBrian J. Mehigan
Brian J. Mehigan
AQAkhtar E. Qureshi
Akhtar E. Qureshi
GDGraham S. Duthie
Graham S. Duthie
PLPeter W. R. Lee
Peter W. R. Lee
JMJohn R. T. Monson
John R. T. Monson
Total mesorectal excision offers the lowest reported rates of local recurrence for rectal cancer; however, the ability to perform total mesorectal excision laparoscopically remains unproven. The aim of this study was to assess the feasibility and adequacy of a totally laparoscopic total mesorectal excision for rectal cancer. A prospective review of all patients undergoing laparoscopic-assisted surgery for rectal cancer by a single surgeon was undertaken. These were compared with a control group undergoing open rectal resections by another colorectal consultant in the unit (n = 22). Comparison of total specimen length, longitudinal and radial excision margins, and lymph node yield was made between groups. Of 42 laparoscopic-assisted rectal resections attempted, 14 (33 percent) were converted to open procedures and six had their dissection completed open. One resection was considered noncurative. Twenty-one total mesorectal excisions (50 percent) were completed totally laparoscopically. No significant difference was detected between groups for specimen length, radial margin, or lymph node yield. Longitudinal margin of excision was longer in the laparoscopic group (4 (3.5-5) vs. 2.5 (1.05-3.5) cm; P = 0.02, Mann-Whitney). Operating time was significantly longer in the laparoscopic group (180 (168-218) vs. 125 (104-144) minutes; P = 0.003, Mann-Whitney). Data are medians (interquartile ranges). Four patients in the laparoscopic-assisted group had clinical anastomotic leakage vs. one in the open group (P = 0.329, Fisher's exact test). At median follow-up of 38 (range, 6-53) months, one local recurrence had occurred in each group and crude mortality rates were 29 and 23 percent in the laparoscopic-assisted and open groups, respectively (P = 0.736, Fisher's exact test). Totally laparoscopic excision of the mesorectum is feasible in 50 percent of patients and where possible yields histologic parameters comparable to open surgery. Early survival and recurrence figures also appear to be comparable.

29 May 2016 in Therapeutic Advances in Medical Oncology
Verified
Journal Article
Open access
AMAndrew Moriarity
Andrew Moriarity
JOJacintha O’sUllivan
Jacintha O’sUllivan
JKJohn Kennedy
John Kennedy
BMBrian Mehigan
Brian Mehigan
PMPaul McCormick
Paul McCormick
Treatment strategies for metastatic colorectal cancer (mCRC) patients have undergone dramatic changes in the past decade and despite improved patient outcomes, there still exist areas for continued development. The introduction of targeted agents has provided clinicians with additional treatment options in mCRC, however, results have been mixed at best. These novel therapies were designed to interfere with specific molecules involved in the cellular carcinogenesis pathway and ultimately deliver a more focused treatment. Currently, their use in mCRC has been limited primarily as an adjunct to conventional chemotherapy regimens. This review explores the relevant cell-signaling networks in colorectal cancer, provides focus on the current targeted agent armamentarium approved for use in mCRC and explores the usefulness of predictive mCRC biomarkers.

1 August 2000 in Annals of Surgery
Verified
Journal Article
Closed access
JHJohn E. Hartley
John E. Hartley
BMBrian J. Mehigan
Brian J. Mehigan
AMAlastair W. MacDonald
Alastair W. MacDonald
PLPeter W. R. Lee
Peter W. R. Lee
JMJohn R. T. Monson
John R. T. Monson
To determine whether survival and recurrence after laparoscopic-assisted surgery for colorectal cancer is compromised by an initial laparoscopic approach. Laparoscopic colorectal resection for malignancy remains controversial 8 years after its first description. Fears regarding compromised oncologic principles and early recurrence (particularly the phenomenon of port-site metastases) have tempered enthusiasm for this approach. Long-term follow-up data are at present scarce. A prospective comparative trial was undertaken between December 1993 and May 1996, during which 114 patients had laparoscopic-assisted resection by a single laparoscopic colorectal surgeon or conventional open surgery by a second specialist colorectal surgeon. Intensive follow-up for at least 2 years is available on 109 patients. Analysis was performed on an intention-to-treat basis. Recurrent disease has developed in 27 patients (25%), 16 of 57 in the laparoscopic group (28%) and 11 of 52 in the conventional group (21%). Crude death rates are 26/57 (46%) in the laparoscopic group and 24/52 (46%) in the conventional group. No port-site metastases have occurred; however, wound metastases associated with disseminated disease have developed in three patients in the open group and one in the laparoscopic group. Stage-for-stage survival and recurrence figures are comparable. Oncologic outcome at a minimum of 2 years is not compromised by the laparoscopic approach. Wound recurrences are a feature of laparoscopic and conventional surgery for advanced disease.

20 June 2010 in International Journal of Colorectal Disease
Verified
Journal Article
Closed access
PDF file
LHLaura A. Healy
Laura A. Healy
ARAoife M. Ryan
Aoife M. Ryan
ESEllis Sutton
Ellis Sutton
KYKatherine Younger
Katherine Younger
BMBrain Mehigan
Brain Mehigan
JRJohn V. Reynolds
John V. Reynolds